Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1039-42Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-06-02 / Cancer Immunol. Immunother. 2013 Aug;62(8):1381-92Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-11-01 / Clin. Exp. Immunol. 2012 Nov;170(2):167-77Cellular immunotherapy using dendritic cells against multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-03-28 / Korean J Hematol 2012 Mar;47(1):17-27Immunotherapy using dendritic cells against multiple myeloma: how to improve?
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-03-15 / Clin. Dev. Immunol. 2012;2012:397648Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2011-01-01 / J. Immunother. 2011 Jan;34(1):100-6Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-10-28 / Blood 2011 Jan;117(2):393-402Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-07-07 / Br. J. Haematol. 2010 Sep;150(5):554-64Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-01-01 / Neoplasma 2010;57(5):455-64IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de